AREV — AREV Life Sciences Global Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesSpeculativeMicro Cap
Annual cashflow statement for AREV Life Sciences Global, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.27 | -3.19 | -1.05 | -0.99 | -1.44 |
| Depreciation | |||||
| Non-Cash Items | 7.31 | 2.39 | 0.443 | -0.302 | 0.178 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.199 | 0.62 | 0.434 | -0.324 | 0.856 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -1.1 | -0.114 | -0.024 | -1.47 | -0.284 |
| Capital Expenditures | -0.05 | -0.215 | -0.403 | -0.012 | -0.082 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.527 | 0 | -0.033 | 0.06 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.577 | -0.215 | -0.436 | 0.048 | -0.082 |
| Financing Cash Flow Items | 0.025 | 0 | 0.098 | 0.007 | 0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.63 | 0.35 | 0.728 | 1.28 | 0.208 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.05 | 0.021 | 0.268 | -0.139 | -0.158 |